Deutsch
TU Dresden

search
Summer University at CRTD
Stem cells & sensory organs - this was the motto... [read more]
© CRTD
13th CRTD Summer Conference offered great scientific exchange
180 scientists and company representatives assembled on June 28, 2019 [read more]
Summer Conference © CRTD
The POInT study is growing
More than a year ago, the Freder1k study was expanded to include the "POInT study: Primary Oral Insulin Trial". [read more]
State Secretary Uwe Gaul opened the 1st POInT Summer Party at the CRTD © Kathleen Biermann-Jung
Widespread disease diabetes: Why do beta cells refuse to release insulin?
New insights into the "teamwork" of cells: Super-connected "leader" cells coordinate insulin response and help us to understand how diabetes develops One in eleven adults... [read more]
Cover of Nature Metabolism, June 2019
Rise and shine to science
CRTD, B CUBE and BIOTEC welcomed more than 2,000 visitors to the 17th Dresden Science Night [read more]
Dresden Science Night © Friederike Braun
CRTD researchers bring innovation from bench to bedside
Novel process for the production of suppressive T cells The Center for Regenerative Therapies (CRTD) at the TU Dresden and the University Hospital Carl Gustav Carus have successfully... [read more]
The Good Manufacturing Practice (GMP) Facility of the CRTD © CRTD
How fish brain cells react to Alzheimer’s disease
Zebrafish, in contrast to humans, have outstanding regenerative capacities: If brain cells are lost due to illness or injury, they will easily regrow from so-called progenitor cells. With... [read more]
© Caghan Kizil / DZNE
What happens in the body of ALS patients?
Scientists from TU Dresden find ways to reduce the number of dying neurons and search for therapeutic approaches to treat ALS   Amyotrophic lateral sclerosis (ALS) is an incurable... [read more]
© CRTD

Research at the Center for Regenerative Therapies (CRTD) at TU Dresden focuses on discovering principles of cell and tissue regeneration, and leveraging this for recognition, treatment, and reversal of diseases. The CRTD is well positioned for this challenge with its diversity in model organisms, organs, and disease systems and its range of methodological approaches from basic research to validation projects and clinical studies. The CRTD links the bench to the clinic, and scientists to clinicians to bring expertise in stem cells, gene-editing, and regeneration towards innovative therapies for metabolic, osteo-hematological, and neurological diseases.